← Leaderboards
Guowei Su
Glycan Therapeutics Corporation
$5,499,306
Attributed
$5,499,306
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,499,306 · 4
By mechanism
R44$4,817,672 · 2
R43$681,634 · 2
Top collaborators
No co-investigators on record.
Most similar at Glycan Therapeutics Corporation
Same institution · by research overlap
- Vijayakanth Pagadala$12,153,122
- Yongmei Xu$1,933,798
- Zhangjie Wang$4,365,125
- Katelyn Arnold$1,234,308
- Quin Shi$299,447
Others in their field
Other Emerging Leaders on “Phase 1 Study”
- Yunda Huang · Fred Hutchinson Cancer Center$66,434,461
- Martha Hering · Westat, Inc.$57,098,843
- Julie Ake · National Institute Of Allergy And Infectious Diseases$50,742,120
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,015,727
Research focus
Phase 1 StudySulfateStructurePolysaccharidesOligosaccharidesServicesInnovationBiologicalMicroarray AnalysisPlayPatternPreparationGrantBiological ProcessHeparitin SulfateCommunitiesDesignLibrariesAcademiaPublishingGenerationsCollaborationsMass Spectrum AnalysisMember
Grant awards (7)
Synthesis of the library of heparan sulfate hexasaccharide mimetics$1,075,790
R44 · FY2025 · GM · contact PI
Synthesis of the library of heparan sulfate hexasaccharide mimetics$1,075,154
R44 · FY2024 · GM · contact PI
Development of a sensitive method to measure heparan sulfate 6-O-endosulfatase$350,000
R43 · FY2023 · GM · contact PI
Synthesis of the library of heparan sulfate hexasaccharide mimetics$255,001
R44 · FY2023 · GM · contact PI
Construction of chondroitin sulfate microarray$331,634
R43 · FY2022 · GM · contact PI
Developing Heparan Sulfate Glycan Array$968,047
R44 · FY2021 · GM · contact PI
Developing Heparan Sulfate Glycan Array$1,443,680
R44 · FY2020 · GM · contact PI